GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement
Thursday, July 24, 2008 - 08:49
in Biology & Nature
GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.read more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Daley and colleagues create 20 disease-specific stem cell linesThu, 7 Aug 2008, 12:37:21 EDT
- NY Stem Cell Foundation plays critical funding role in major new ALS research announced todayThu, 31 Jul 2008, 16:36:32 EDT
- Neurons created from skin cells of elderly ALS patientsThu, 31 Jul 2008, 14:43:08 EDT
- Stem cell discovery sheds light on placenta developmentMon, 9 Jun 2008, 14:14:50 EDT
- Team led by Scripps Research scientists develop method for generating novel types of stem cellsThu, 18 Dec 2008, 12:30:28 EST